ADCT(ADC Therapeutics SA) · 财务报表

ADCT(ADC Therapeutics SA) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$209.91M$69.56M$70.84M$81.36M
毛利润$206.61M$67.03M$64.89M$75.56M
营业利润−$123.34M−$165.99M−$130.65M−$121.50M
净利润−$157.13M−$240.05M−$157.85M−$142.62M
经营现金流−$138.31M−$118.69M−$123.83M−$141.17M
自由现金流−$139.00M−$121.90M−$124.70M−$141.44M
摊薄每股收益$-2.01$-2.94$-1.62$-1.12

ADC Therapeutics SA ADCT